Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: Alteration of the gut microbiome in mycophenolate-induced enteropathy: impacts on the profile of short-chain fatty acids in a mouse model

Fig. 2

SCFA profile in faecal samples. Acetate (A), propionate (B), and butyrate (C) concentration in control and MMF-treated mice at days 0, 4 and 8. (D) PLS-DA score plot of all SCFA in control and MMF-treated mice according to time (days 0, 4 and 8). #One missing data due to sample contamination. Statistical significance was assessed by two-way ANOVA followed by post-hoc Bonferroni multiple comparison test (A, B, C). *, p < 0.05; **, p < 0.01; ***, p < 0.001. n = number of mice

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us